News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CLC bio Delivers Specialized Antibody Engineering and Selection Software for Crucell N.V. (CRXL)


6/8/2012 9:33:51 AM

LEIDEN, Netherlands & AARHUS, Denmark--(BUSINESS WIRE)--Today CLC bio announced the completion and final implementation of a specialized antibody engineering and selection module for Crucell, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, that integrates with CLC bio's bioinformatics platform. The specialized module is designed to optimize the end-to-end workflow and analysis pipeline when working with a large number of antibodies during the process of developing new therapies for various diseases amongst which infectious diseases and cancer

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES